2-[(4-BroMophenyl)sulfonyl]fluorobenzene
- $195 - $550
- Product name: 2-[(4-BroMophenyl)sulfonyl]fluorobenzene
- CAS: 1807542-95-5
- MF: C12H8BrFO2S
- MW: 315.16
- EINECS:
- MDL Number:MFCD28014562
- Synonyms:2-[(4-BroMophenyl)sulfonyl]fluorobenzene;Benzene, 1-[(4-bromophenyl)sulfonyl]-2-fluoro-
4 prices
Selected condition:
Brand
- AK Scientific
- Alichem
- Crysdot
Package
- 250mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product number1033EA
- Product description1-((4-Bromophenyl)sulfonyl)-2-fluorobenzene
- Packaging1g
- Price$323
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number1033EA
- Product description1-((4-Bromophenyl)sulfonyl)-2-fluorobenzene
- Packaging250mg
- Price$195
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1807542955
- Product description1-((4-Bromophenyl)sulfonyl)-2-fluorobenzene
- Packaging5g
- Price$527.73
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12103593
- Product description1-((4-Bromophenyl)sulfonyl)-2-fluorobenzene 95+%
- Packaging5g
- Price$550
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 1033EA | 1-((4-Bromophenyl)sulfonyl)-2-fluorobenzene | 1g | $323 | 2021-12-16 | Buy |
AK Scientific | 1033EA | 1-((4-Bromophenyl)sulfonyl)-2-fluorobenzene | 250mg | $195 | 2021-12-16 | Buy |
Alichem | 1807542955 | 1-((4-Bromophenyl)sulfonyl)-2-fluorobenzene | 5g | $527.73 | 2021-12-16 | Buy |
Crysdot | CD12103593 | 1-((4-Bromophenyl)sulfonyl)-2-fluorobenzene 95+% | 5g | $550 | 2021-12-16 | Buy |
Properties
Boiling point :419.6±30.0 °C(Predicted)
Density :1.590±0.06 g/cm3(Predicted)
Density :1.590±0.06 g/cm3(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|